More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the ...

Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes: Ingelheim, Germany Wednesday, November 13, 2024, 10:00 Hrs [IST] Boehringer Ingelheim and the ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure ...

Nov. 13, 2024 /PRNewswire/ -- TileDB, the database designed for scientific discovery, announced today it is now utilized by 50% of the top 20 global pharmaceutical companies, including industry giant ...

Nov. 13, 2024 /PRNewswire/ — TileDB, the database designed for scientific discovery, announced today it is now utilized by 50% of the top 20 global pharmaceutical companies, including industry giant ...

Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...

Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...

The non-cystic fibrosis bronchiectasis market is driven by rising prevalence linked to respiratory infections, autoimmune diseases, and COPD. Increasing awareness among healthcare providers and ...